Accumulation of genetic changes during the development and progression of bladder cancer
Cianciulli, A.M.; Merola, R.; Vico, E.; Orlandi, G.; Sentinelli, S.; Gallucci, M.
Pathologica 97(4): 177-178
2005
ISSN/ISBN: 0031-2983 PMID: 16440640 Document Number: 588694
Document emailed within 1 workday
Related Documents
Yokota, J.; Ookawa, K. 1993: Accumulation of genetic alterations during human tumor progression Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(3): 321-325Del Zingaro, M.; Bruno, R.; Nunzi, E.; Porena, M.; Mearini, L. 2016: First and second transurethral resections in intermediate-high risk bladder cancer: impact of the surgeon's volume on the recurrence and progression of primary bladder cancer Minerva Urologica e Nefrologica 68(2): 194-203
Soucek, P. 2001: Role of genetic factors in development and progression of non-Hodgkin's lymphomas Central European Journal of Public Health 9(2): 74-78
Mokos, I.; Jakić-Razumović, J.; Mareković, Z.; Pasini, J. 2006: Association of cyclooxygenase-2 immunoreactivity with tumor recurrence and disease progression in superficial urothelial bladder cancer Tumori 92(2): 124-129
Sanjo, H.; Ito, Y.; Osaka, K.; Komiya, A.; Kobayashi, K.; Sakai, N.; Noguchi, S.; Kishi, H. 2012: Metastatic micropapillary variant of the urinary bladder: progression from low grade non-muscle invasive bladder carcinoma Hinyokika Kiyo. Acta Urologica Japonica 58(8): 447-451
Teishima, J.; Matsubara, A. 2016: Mechanism of development and progression in prostate cancer: Overview Nihon Rinsho. Japanese Journal of Clinical Medicine 74(Suppl 3): 80-86
Shimazaki, J. 1998: Development and progression of prostate cancer in relation with androgen dependency Nihon Rinsho. Japanese Journal of Clinical Medicine 56(8): 1953-1958
Jenster, G. 1999: The role of the androgen receptor in the development and progression of prostate cancer Seminars in Oncology 26(4): 407-421
Ponz de Leon, M.; Pedroni, M.; Benatti, P.; Percesepe, A.; Rossi, G.; Genuardi, M.; Roncucci, L. 1999: Epidemiologic and genetic factor in colorectal cancer: development of cancer in dizygotic twins in a family with Lynch syndrome Italian Journal of Gastroenterology and Hepatology 31(3): 218-222
Kasamatsu, E.S.; Mitani, G.; Yamada, T. 1971: Histopathological changes in the development of bladder cancer Gan no Rinsho. Japan Journal of Cancer Clinics 17(10): 719-726
Mombello, A.; Mariuzzi, L.; Morelli, L.; Granchelli, G.; Rucco, V.; Tarocco, E.; da Silva, V.D.; Thompson, D.; Bartels, H.G.; Bartels, P.H.; Mariuzzi, G. 2001: Quantitative study of ductal breast cancer progression: nuclear signatures for evaluation of progression grade Advances in Clinical Pathology: the Official Journal of Adriatic Society of Pathology 5(3): 59-70
Schroeder, T.M. 1972: Genetic factors in the development of cancer Fortschritte der Medizin 90(16): 603-608
Shekarsarai, H.; Zlotta, A.R.; Drowart, A.; Van Vooren, J.P.; De Cock, M.; Pirson, M.; Palfliet, K.; Jurion, F.; Vanonckelen, A.; Simon, J.; Schulman, C.C.; Huygen, K. 1997: The need of prolonged BCG treatment in superficial bladder cancer is suggested by the development of a peripheral immune response induced by BCG Acta Urologica Belgica 65(1): 1-4
Xu, W.H.; Dai, Q.; Xiang, Y.B.; Long, J.R.; Ruan, Z.X.; Cheng, J.R.; Zheng, W.; Shu, X.O. 2007: Interaction of soy food and tea consumption with CYP19A1 genetic polymorphisms in the development of endometrial cancer American Journal of Epidemiology 166(12): 1420-1430
Mommsen, S.; Jakobsen, A.; Sell, A. 1989: Quality of life in patients with advanced bladder cancer. a randomized study comparing cystectomy and irradiation--the Danish Bladder Cancer Study Group (DAVECA protocol 8201) Scandinavian Journal of Urology and Nephrology. Supplementum 125: 115-120
Aihara, R.; Sato, K.; Sasaki, K.; Hosaka, Y.; Narita, T. 1985: Pre and postoperative nursing of patients with bladder cancer. Nursing of a patient in the terminal stage of bladder cancer with poor prognosis Nursing Technique 31(11): 1492-1497
Reddel, R.R.; Alexander, I.E.; Koga, M.; Shine, J.; Sutherland, R.L. 1988: Genetic instability and the development of steroid hormone insensitivity in cultured T 47D human breast cancer cells Cancer Research 48(15): 4340-4347
Kozuszko, B.; Skrzydlewski, Z.; Sulkowska, M.; Snarska, J.; Kozłowski, M.; Skrzydlewska, E.; Zalewski, B. 2001: Cancer procoagulant activity in cases of esophageal, stomach and colorectal cancer considering progression degree and histological type of cancer Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 11(63): 218-220
Obata, J.; Nakamura, T.; Kuroyanagi, R.; Yoshida, Y.; Guo, D.F.; Inagami, T. 1997: Candesartan prevents the progression of glomerulosclerosis in genetic hypertensive rats Kidney International. Supplement 63: S229-S231
Beltran, A.L.; Ordonez, J.L.; Otero, A.P.; Blanca, A.; Sevillano, V.; Sanchez-Carbayo, M.; Kirkali, Z.; Cheng, L.; Montironi, R.; Prieto, R.; De Alava, E. 2013: Fluorescence in situ hybridization analysis of CCND3 gene as marker of progression in bladder carcinoma Journal of Biological Regulators and Homeostatic Agents 27(2): 559-567